Companies/US/CTKB

CYTEK BIOSCIENCES, INC.

Income flow

Annual
CTKB 10-K Income StatementPeriod 2025-12-31Source 10-K
Reportable Segment$201MRevenue$201MGross profit$104MCost of revenue$97M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$201M
  • Reportable Segment$201M100.0%
By geography
By geography$222M
  • United States$95M42.9%
  • EMEA$56M25.2%
  • Asia Pacific$41M18.5%
  • CN$21M9.2%
  • Other$9M4.2%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).130.0MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).102.9M